Back to search

Article

Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasis

2020-11-20

Abstract excerpt

Visceral Leishmaniasis (VL) is fatal if untreated. There is no licensed vaccine available against human leishmaniasis. We recently demonstrated protection in mice against L. major infection using a CRISPR genome edited attenuated Leishmania major strain ( LmCen −/− ). Here, as a pre-clinical step, we evaluated the protective efficacy of LmCen −/− against VL induced by sand fly transmitted Leishmania donovani...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
315e02b3-b367-5f5d-ba71-c9c201fe9f10
DOI
10.1101/2020.11.18.388553
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasisDOI 10.1101/2020.11.18.388553
Select a neighboring publication to make it the new centre.